{"id":41776,"date":"2018-04-04T11:26:23","date_gmt":"2018-04-04T10:26:23","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=41776"},"modified":"2018-04-10T13:16:29","modified_gmt":"2018-04-10T12:16:29","slug":"stephen-a-matlin-the-polio-dividend-opportunities-and-challenges","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/","title":{"rendered":"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges"},"content":{"rendered":"<p><span style=\"font-weight: 400\"><a href=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/Matlin_-Stephen.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-41778\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/Matlin_-Stephen.jpg\" alt=\"\" width=\"160\" height=\"160\" srcset=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/Matlin_-Stephen.jpg 160w, https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/Matlin_-Stephen-150x150.jpg 150w\" sizes=\"auto, (max-width: 160px) 100vw, 160px\" \/><\/a>On the brink of completing its mission to eradicate polio <\/span><span style=\"font-weight: 400\">worldwide<\/span><span style=\"font-weight: 400\">, the <\/span><a href=\"http:\/\/polioeradication.org\/who-we-are\/\"><span style=\"font-weight: 400\">Global Polio Eradication Initiative (GPEI)<\/span><\/a><span style=\"font-weight: 400\"> is now ramping down in preparation for closure. There were only 22 cases of polio caused by the wild poliovirus in 2017, occurring in Afghanistan and Pakistan.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Polio eradication has been the longest, largest, most expensive global health programme ever, with an investment of more than US$15 billion over 30 years. It has been managed <\/span><span style=\"font-weight: 400\">by the GPEI, which is <\/span><span style=\"font-weight: 400\">a partnership hosted at the World Health Organization (WHO) and involving UNICEF, the US Centers for Disease Control, Rotary International, and the Bill and Melinda Gates Foundation.<\/span><\/p>\n<p><span style=\"font-weight: 400\">There are great opportunities for a \u201cpolio dividend\u201d. First and foremost, this consists of the global public good of ending a disease in human beings for only the second time in history. When the GPEI began in 1988, polio was prevalent in 125 countries, and \u00a0caused lifelong paralysis and sometimes death in over 350,000 people per year, particularly in children. Subsequently, more than 16 million polio cases globally have been averted. However, eradication is not yet complete and outbreaks of vaccine-related polio in Syria and Ukraine in recent years have demonstrated that Europe, like the rest of the world, remains vulnerable unless vigilance and high levels of vaccine coverage are sustained.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The second dividend can arise from the polio assets developed during the last 30 years, These assets include vaccination systems, skilled health workers and programme managers, and surveillance, laboratory analysis and tracking capacities. These assets can be extremely valuable if they are transitioned to the ownership of countries trying to build strong and resilient health systems. Survival of these assets requires transferring them out of the polio silo, by making concrete, durable links with other health programmes and initiatives.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The money that will be \u00a0freed up when donors are no longer funding the GPEI constitutes a third potential dividend, but there are risks that this resource will no longer be spent on \u00a0global health. For example, the UK has been the second largest national contributor to the GPEI (after the USA), investing about US$ 1.6 billion over 30 years. But there is a lack of clarity at present about whether the money currently spent on polio will be transferred to other global health objectives and, if so, which. Two interlinked areas where there is currently much debate are around \u00a0support for the transitioning of polio assets and the broader issue of WHO financing.<\/span><\/p>\n<p><span style=\"font-weight: 400\">The donors&#8217; commitments to GPEI end with polio eradication. Post-eradication management of transitioned polio assets will need to be addressed separately, particularly through bilateral support to assist poor countries to absorb and maintain the assets. The difficulty in making the case for this investment is compounded by a lack of clear definitions and endpoints for \u201ctransitioning\u201d and of agreement on what constitutes a \u201cgood\u201d health system.<\/span><\/p>\n<p><span style=\"font-weight: 400\">As the host of the GPEI, about 20% of WHO\u2019s recent financing has derived from the polio funding stream. Closure of the GPEI re-exposes the chronic, severe, under-funding of the WHO by Member States. The issue will be at the core of discussions at the May 2018 World Health Assembly and WHO Executive Board. Resolving it will have a major influence on the future directions and capacities of WHO.<\/span><\/p>\n<p><span style=\"font-weight: 400\">A further polio asset of particular value for the international community is the knowledge accumulated during the biggest global health programme in history: knowledge of how to organise, manage, and sustain a global programme; of what works and what does not; of how to overcome political as well as technical, organizational, and financial challenges; and of what not to do in the future as well as what should be done, if past mistakes are not to be repeated. There is already debate about what disease might next be targeted for elimination, but not everyone is convinced that the decision should be taken soon, or that another \u201cvertical\u201d programme is the best way to use limited health resources.<\/span><\/p>\n<p><span style=\"font-weight: 400\">WHO Director-General Dr Tedros is among those who have noted that <\/span>&#8220;health is a political choice.&#8221;<span style=\"font-weight: 400\">\u00a0The global health community, donors and political leaders should make <\/span><span style=\"font-weight: 400\">their <\/span><span style=\"font-weight: 400\">choices carefully and with a long-term vision as<\/span><span style=\"font-weight: 400\"> they take t<\/span><span style=\"font-weight: 400\">he next steps in its engagement in global health.<\/span><\/p>\n<p><span style=\"font-weight: 400\"><em><strong>Stephen A. Matlin<\/strong> is a Senior Fellow in the Global Health Centre at the Graduate Institute of International and Development Studies, Geneva and an Adjunct Professor in the Institute of Global Health Innovation, Imperial College London, UK.<\/em><\/span><\/p>\n<p><strong>Competing interests<\/strong>: None declared.<\/p>\n<p><b>Acknowledgements:\u00a0<\/b><span style=\"font-weight: 400\">This article was developed from discussions at a meeting <\/span><span style=\"font-weight: 400\">in London on 13 March 2018, organized by the Global Health Centre at the Graduate Institute, Geneva, Rotary International and the Wellcome Trust, on <\/span><span style=\"font-weight: 400\">\u2018UK directions and linkages in global health: beyond polio transitioning\u2019.<\/span> <span style=\"font-weight: 400\">The meeting formed part of a work programme of the <\/span><span style=\"font-weight: 400\">Global Health Centre<\/span><span style=\"font-weight: 400\"> funded by the Bill and Melinda Gates Foundation.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On the brink of completing its mission to eradicate polio worldwide, the Global Polio Eradication Initiative (GPEI) is now ramping down in preparation for closure. There were only 22 cases [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":41781,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[263],"tags":[],"class_list":["post-41776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-global-health"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stephen A. Matlin: The polio dividend\u2014opportunities and challenges - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges - The BMJ\" \/>\n<meta property=\"og:description\" content=\"On the brink of completing its mission to eradicate polio worldwide, the Global Polio Eradication Initiative (GPEI) is now ramping down in preparation for closure. There were only 22 cases [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-04T10:26:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-10T12:16:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/polio_baby.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges\",\"datePublished\":\"2018-04-04T10:26:23+00:00\",\"dateModified\":\"2018-04-10T12:16:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/\"},\"wordCount\":809,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/04\\\/polio_baby.jpg\",\"articleSection\":[\"Global health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/\",\"name\":\"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/04\\\/polio_baby.jpg\",\"datePublished\":\"2018-04-04T10:26:23+00:00\",\"dateModified\":\"2018-04-10T12:16:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/04\\\/polio_baby.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/04\\\/polio_baby.jpg\",\"width\":540,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2018\\\/04\\\/04\\\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/","og_locale":"en_US","og_type":"article","og_title":"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges - The BMJ","og_description":"On the brink of completing its mission to eradicate polio worldwide, the Global Polio Eradication Initiative (GPEI) is now ramping down in preparation for closure. There were only 22 cases [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2018-04-04T10:26:23+00:00","article_modified_time":"2018-04-10T12:16:29+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/polio_baby.jpg","type":"image\/jpeg"}],"author":"BMJ","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"BMJ","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges","datePublished":"2018-04-04T10:26:23+00:00","dateModified":"2018-04-10T12:16:29+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/"},"wordCount":809,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/polio_baby.jpg","articleSection":["Global health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/","url":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/","name":"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/polio_baby.jpg","datePublished":"2018-04-04T10:26:23+00:00","dateModified":"2018-04-10T12:16:29+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/polio_baby.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/04\/polio_baby.jpg","width":540,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2018\/04\/04\/stephen-a-matlin-the-polio-dividend-opportunities-and-challenges\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Stephen A. Matlin: The polio dividend\u2014opportunities and challenges"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmj\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/41776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=41776"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/41776\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/41781"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=41776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=41776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=41776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}